China Resources Pharmaceutical Group: Completed the issuance of 1.1 billion yuan in 2025 corporate bonds.

China Resources Pharmaceuticals announced that its wholly-owned subsidiary, China Resources Pharmaceutical Holdings, has completed the public issuance of the second phase of 2025 corporate bonds. The total principal of this bond is 1.1 billion yuan, with a term of three years and a nominal annual interest rate of 1.78%. The net proceeds will be used for productive expenditures, including repaying company debts, supplementing operating funds, project development and operating expenses, investments related to science and technology innovation, and other purposes in compliance with applicable laws and regulations.